skip to Main Content
design lab self-driving nissan toyota ford duke stanford e-hmi

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

Read Next

Designathon

Designing UC San Diego’s New Trolley Stop | Pepper Canyon Mobility Hub Designathon Video

Watch the 14-minute Pepper Canyon Mobility Hub Designathon Video

Over 250 UC San Diego students, neighbors, and future transit users gathered on April 6-7, 2019 for the first-ever Designathon: an intensive, immersive event where interdisciplinary teams design solutions for real-world challenges. This Designathon focused on the Pepper Canyon Station, which aspires to be an ecologically, socially, and technologically friendly mobility hub on the UCSD campus, set to open in 2020.

Executive Producer: Michele Morris
Producers & Directors: Stephanie Sherman, Ash Eliza Smith, Ian Strelsky
Camera Operators: Clint Evangelista, Qiyi Fan, Alice Medrano, Steven Phung, Yimeng Sun
Editors: Steven Phung, Yimeng Sun
Story Consultant: Griffin Middelson
Animators: Weilun Yao, Lilly Gee
Sound Designers: Steven Phung
Music Composers: Remy Rose, Riain Hager, Forrest Reid
Design Lab Remanufacturing Circular Economy Law

Spotlight on Peggy Zwolinski

The Design Lab welcomed Peggy Zwolinski, a visiting scholar from France who is currently working…

Design Lab Connect2health National Cancer Institute

UC San Diego Design Lab Joins FCC, NCI to Champion Critical Role of Broadband in Rural Cancer Care

The Federal Communications Commission’s Connect2Health Task Force (C2HFCC) announced last week that the FCC and the…

Subtance Addiction Digital Health

The Digital Health Landscape in Addiction and Substance Use Research: Will Digital Health Exacerbate or Mitigate Health Inequities in Vulnerable Populations?

A new paper from Design Lab member Camille Nebeker

Novel and emerging digital health technologies are increasingly used in substance use and addiction-related self-management and treatment research. The promise of digital health is exciting, yet there are important factors regarding population characteristics to consider prior to using novel technologies with vulnerable populations. This paper by Camille Nebeker, Design Lab member and UCSD Behavioral Medicine professor, and Dina Hamideh reports a review of scientific literature published between 2015 and early 2020 on the use of digital health strategies in research focused on substance use and addiction in vulnerable populations.
Ailie Fraser UCSD Design Lab

Ailie Fraser Aims to Support People Doing Creative Tasks with Software

“There’s so much helpful content available now, but how can it be understood and consumed by a novice?” asks Ailie Fraser, a PhD graduate, “That’s what I’m interested in answering.” She is a part of a generation of upcoming design innovators, working collaboratively with The Design Lab. Her recently published dissertation aims to support people doing creative tasks with software specifically by leveraging resources generated by experts and bringing them into the context of people's workflows; in order to make them simpler to navigate and understand.

Fraser received her PhD from UCSD in Computer Science this past spring, and is now working full-time as a Research Engineer at Adobe Research. During her PhD, she completed three internships with Adobe Research. During her first internship, she focused on the domain of photo editing in Photoshop and addressed the problems novices experience when they begin to use the application. Due to the plethora of features and tools offered by the service, it can often be overwhelming to those unfamiliar with Photoshop.
Design Lab Remanufacturing Circular Economy Law

Spotlight on Peggy Zwolinski

The Design Lab welcomed Peggy Zwolinski, a visiting scholar from France who is currently working…

Back To Top